Found: 9
Select item for more details and to access through your institution.
No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
- Published in:
- Rheumatology, 2021, v. 60, n. 3, p. 1226, doi. 10.1093/rheumatology/keaa424
- By:
- Publication type:
- Article
Variation in Reported Neonatal Group B Streptococcal Disease Incidence in Developing Countries.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 1, p. 91, doi. 10.1093/cid/cis395
- By:
- Publication type:
- Article
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Rekombinowana adjuwantowa szczepionka przeciwko półpaścowi zmniejsza ból związany z półpaścem oraz redukuje stosowanie leków przeciwbólowych w trzech randomizowanych kontrolowanych placebo badaniach.
- Published in:
- Pain Research / Ból, 2023, v. 24, n. 2, p. 22, doi. 10.5604/01.3001.0053.7735
- By:
- Publication type:
- Article
Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 415, doi. 10.1186/1756-0500-5-415
- By:
- Publication type:
- Article
End-point definition and trial design to advance tuberculosis vaccine development.
- Published in:
- European Respiratory Review, 2022, v. 31, n. 164, p. 1, doi. 10.1183/16000617.0044-2022
- By:
- Publication type:
- Article
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.
- Published in:
- 2018
- By:
- Publication type:
- journal article